Skip to main content
. 2018 Jun 18;8(3):425–433. doi: 10.1007/s13555-018-0247-0

Fig. 3.

Fig. 3

Percentage reduction in AK count since baseline, complete clearance, and absolute reduction in AK count since baseline by baseline AK count. Pooled data from Studies 1–6, ingenol mebutate treatment groups